Marshall Wace »

Affimed Therapeutics B V shares owned by Marshall Wace

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $383k 607k 0.63
2022-03-31 $976k 223k 4.37
2021-09-30 $1.1M 179k 6.19

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Affimed Therapeutics B V

Ridgeback Capital Investments
683 Capital Management
NEA Management Company
Point72 Asset Management
Millennium Management
Vanguard Group
Two Sigma Advisers
Kennedy Capital Management
Two Sigma Investments
Marshall Wace
Alyeska Investment Group
Standard Life Aberdeen
Ewa
Wells Fargo & Company
Two Sigma Securities

View all funds holding Affimed Therapeutics B V